GKWIM
NVAX icon

Gerber Kawasaki Wealth & Investment Management’s Novavax NVAX Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8
Closed -$8K – 815
2021
Q3 		$8K Buy
+8
New +$1.76K ﹤0.01% 683

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's NVAX Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Novavax (NVAX) in Q4 2021, closing a stake of 8 shares — an estimated $8K sold.

Gerber Kawasaki Wealth & Investment Management first reported a position in NVAX in Q3 2021 and held it in 1 quarter. The position peaked at $8K in Q3 2021. 430 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Novavax position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 8 Novavax shares in Q4 2021, an estimated $8K.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Novavax in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Novavax position peaked at $8K in Q3 2021.
  • 430 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.